Back to FRONTIER CAPITAL MANAGEMENT CO LLC

BBIO
Showing 8 of 9 quarters

Position history for FRONTIER CAPITAL MANAGEMENT CO LLC's holdings in BRIDGEBIO PHARMA INC

FRONTIER CAPITAL MANAGEMENT CO LLC holds 957,989 shares of BBIO (BRIDGEBIO PHARMA INC), worth $71.1M as of 2026-Q1. The position was increased (+16.0% shares). BBIO represents 0.7% of FRONTIER CAPITAL MANAGEMENT CO LLC's portfolio.

Current Value

$71.1M

Current Shares

957,989

Total Value Change

+$67.4M

Total Shares Change

+809,621

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
957,989
+16.0%
$71.1M0.7%$64.53
48
2025-Q4
Increased
826,131
+25.2%
$63.2M0.7%$75.48
51
2025-Q3
Increased
659,633
+23.1%
$34.3M0.3%$51.96
42
2025-Q2
Decreased
535,763
-30.4%
$23.1M0.2%$44.86
0
2025-Q1
Decreased
769,301
-28.5%
$26.6M0.3%$35.11
0
2024-Q4
Increased
1.1M
+113.8%
$29.5M0.3%$27.32
56
2024-Q3
Increased
503,162
+239.1%
$12.8M0.1%$24.94
54
2024-Q2
Decreased
148,368
-67.0%
$3.8M0.0%$25.33
0

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used